Fierce Pharma
JULY 18, 2023
On the heels of wrapping up a $15 billion share buyback program, Novartis has unveiled another stock repurchase plan of the same size. | On the heels of wrapping up a $15 billion share buyback, Novartis has unveiled another stock repurchase plan of the same size. This comes even as the company's top-selling drug, Entresto, faces patent challenges.
MedCity News
JULY 18, 2023
More than half of employees said they don’t have mental health benefits in their benefit package or aren’t sure if they do, according to a new survey. About two-thirds of respondents said they would use a digital mental health benefit if it was offered to them.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
JULY 18, 2023
In the world of drug packaging, a vial is a vial, the product the product, and never the twain shall meet. When those standards start to slip, recalls are sure to follow. | In tandem with Taiwan’s Food and Drug Administration, GSK this week initiated a recall of two batches of its severe asthma injection Nucala after glass fragments were found in a vial of the drug.
Copyright Clearance Center
JULY 18, 2023
July 18, 2023 – Danvers, Mass. – CCC , the leading provider of Open Access (OA) workflow solutions, announces an enhancement to the processing of OA Agreements for university library consortia in its innovative scholarly communications workflow solution for the OA community, RightsLink for Scientific Communications (RLSC). Earlier this year, CCC engaged with members of the ESAC Initiative and administrators at university libraries representing nine global consortia across the U.S. and Europe to
Fierce Pharma
JULY 18, 2023
Johnson & Johnson has hopped on the litigation bandwagon, becoming the fourth large drugmaker to sue the U.S. government over drug price negotiations in the Inflation Reduction Act (IRA). | Johnson & Johnson has hopped on the litigation bandwagon, becoming the fourth Big Pharma company to sue the U.S. government over drug price negotiations in the Inflation Reduction Act.
PM360
JULY 18, 2023
Digital Health Networks , a global leader in healthcare-focused original content production and OTT streaming, announced the list of judges for the inaugural CINEHEALTH International Film and Video Festival where “The CINEHEALTH Awards” will be presented in the following categories: Feature Films, TV episodic series, short-form videos, social media, and TikTok reels.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
European Pharmaceutical Review
JULY 18, 2023
A market report by Meticulous Research has reported that rising pressure to reduce overall process costs has meant many pharma and biotech manufacturers are focusing on streamlining their processes by using quality management systems. According to the research, the pharmaceutical quality management systems market is projected to reach $3.97 billion by 2030.
PharmaTech
JULY 18, 2023
Jeff Fischer, co-founder and president of Longhorn Vaccines and Diagnostics, discusses the history and ongoing development of both protein- and mRNA-based vaccines.
MedCity News
JULY 18, 2023
A new survey revealed that 64% of clinicians feel physically unsafe at work. The perceived risk of violence was especially high among women, clinicians under age 40, emergency department physicians and employees who work with patients struggling with addiction or other mental health conditions.
PharmExec
JULY 18, 2023
An insightful discussion about how Meta's newest social media platform, Threads, is quickly adding another facet to the digital landscape for pharma marketers.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
MedCity News
JULY 18, 2023
Over the past decade, a significant percentage of the country’s physicians have shifted from working in private practices (defined as those owned wholly by physicians) to working in bigger, health system-owned practices. The ability to negotiate higher payment rates with insurers when working at a larger practice is a crucial factor causing this trend, according to a new AMA analysis.
Medgadget
JULY 18, 2023
Researchers at the University of British Columbia have developed a protein-based hydrogel that is highly adapted for articular cartilage repair. A major challenge in creating biomaterial therapies to repair damaged articular cartilage is matching the mechanical properties of this highly specialized tissue. Cartilage is very tough, resisting breaking under force, but also very stiff, meaning that it resists being bent or deformed.
MedCity News
JULY 18, 2023
Quantum Health has bolstered its collaboration with Sword Health by integrating MSK services to members to track home exercise, avoid unnecessary surgery and support treatment of pelvic conditions.
Pharmaceutical Technology
JULY 18, 2023
Scribe Therapeutics and Sanofi have expanded partnership to progress the development of in vivo genetic therapies to treat genomic diseases.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
MedCity News
JULY 18, 2023
Novartis’s acquisition of DTx Pharma brings a lead program for a rare disease with no FDA-approved therapies. But the deal could also help the pharma giant bring new RNA therapies to new places in the body, a top Novartis executive explained.
PharmaVoice
JULY 18, 2023
Meta’s new platform is drawing Twitter comparisons and could hold potential for pharma marketers in patient and HCP communication.
MedCity News
JULY 18, 2023
Herself Health’s $26 million Series A funding round was led by Michael Cline, founding managing partner of Accretive, and included participation from Juxtapose. It comes six months after Herself Health raised $7 million in seed funding. In total, the company has raised $33 million.
Copyright Clearance Center
JULY 18, 2023
The post Oable and RightsLink Partner to Support Open Access Workflows in Libraries Worldwide appeared first on Copyright Clearance Center.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
MedCity News
JULY 18, 2023
Pfizer and Flagship Pioneering are partnering in a drug research alliance leveraging the capabilities of the more than 40 biotech startups in the venture capital firm’s portfolio. The new partners aim to develop drugs for unmet needs, including those in broad patient populations.
Copyright Clearance Center
JULY 18, 2023
Info pros bring a unique skillset to data management. Here’s advice to get involved and showcase your value in these projects.
Pharmaceutical Technology
JULY 18, 2023
The EC, the Heads of Medicines Agencies (HMA), and the EMA have issued recommendations to prevent shortages of antibiotics.
MedCity News
JULY 18, 2023
When facilities operate their own acute dialysis operations and no longer enlist third parties to provide treatment, they save hundreds of dollars per session. Insourcing also enables hospitals to keep trained dialysis staff on hand full-time to actively ensure quality kidney care to their patients.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
PharmaTimes
JULY 18, 2023
Company’s phase 3 research showed the importance of running biomarker-powered clinical trials - News - PharmaTimes
Evolve Your Success
JULY 18, 2023
By working smarter, owning your value, and confidently communicating your strengths, you can pave the way for a successful career in medical sales. In this episode, Samuel Adeyinka interviews Keila Resto , who shares her inspiring journey of breaking into the world of electrophysiology med device sales. Keila discusses the unique challenges faced by aspiring professionals in this field and highlights the rigorous nature of the interview process.
PharmaTimes
JULY 18, 2023
The partnership will expand Arrayjet’s small molecule microarray drug discovery offerings - News - PharmaTimes
Nixon Gwilt Law
JULY 18, 2023
On June 22, 2023, the Department of Health and Human Services announced a new Medicare coverage pathway called the Transitional Coverage for Emerging Technologies (TCET) pathway. The TCET pathway is limited to novel medical devices and device-led combination products with FDA-designated Breakthrough Device status awaiting full FDA approval. The new pathway provides device manufacturers a unique opportunity to receive extensive support from the Centers for Medicare & Medicaid (CMS) while seek
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
PharmaVoice
JULY 18, 2023
A former WHO epidemiologist is applying lessons learned during the Ebola epidemic to her work leading a company at the forefront of women’s health: the reproductive microbiome.
Healthcare Success
JULY 18, 2023
People often confuse marketing and public relations (PR), but they are not synonymous. They do, however, work best together. In fact, we often include healthcare PR services in our marketing plans along with other key strategies, including branding, digital marketing, traditional advertising, internal marketing, and professional referral building. So, What Exactly Is PR?
Pharmaceutical Technology
JULY 18, 2023
In the healthcare industry, AI is unlocking new possibilities and solving grand healthcare challenges by improving care outcomes, life science innovation, and patient experience in unimaginable ways.
Legacy MEDSearch
JULY 18, 2023
ReddyPort announced today that the US Food and Drug Administration (FDA) granted 510(k) premarket clearance for the ReddyPort elbow device used in non-invasive ventilation (NIV). “ReddyPort’s patented elbow is central to the eco-system we are building to help mitigate clinical obstacles tied to NIV therapy from dry-mouth, oral biofilm accumulation to speech recognition,” says Tony Lair, ReddyPort CEO.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Expert insights. Personalized for you.
200 
Let's personalize your content